Active Specific Intranodal Immunotherapy using Recombinant Vaccinia Virus
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Active Specific Intranodal Immunotherapy using Recombinant Vaccinia Virus, covering 2009-12-02 to 2009-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma [Phase 1, Phase 2]